Is occupational organic solvent exposure a risk factor for scleroderma?

Arthritis and Rheumatism

Volumn 41, Issue 6, 1998, Pages 1111-1118

  Nietert, Paul J ^a   Sutherland, Susan E ^a   Silver, Richard M ^a   Pandey, Janardan P ^a   Knapp, Rebecca G ^a   Hoel, David G ^a   Dosemeci, Mustafa ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; ORGANIC SOLVENT; TRICHLOROETHYLENE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; STATISTICAL ANALYSIS; SYSTEMIC SCLEROSIS;

ADULT; AGED; ANTIBODIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; OCCUPATIONAL EXPOSURE; ORGANIC CHEMICALS; RISK FACTORS; SCLERODERMA, SYSTEMIC; SOLVENTS; TRICHLOROETHYLENE;

EID: 0031780295     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199806)41:6<1111::AID-ART19>3.0.CO;2-J     Document Type: Article

References (35)

1. Reinl V. Sklerodermie durch trichlorathylen-einwirkung? Zentralbl Arbeitsmed 1957;7:58-60.
2. Bolt H, Filser J. Irreversible binding of chlorinated ethylenes to macromolecules. Environ Health Perspect 1977;21:107-12.
3. Rocci P, Prodi G, Grilli S, Ferreri A. In vivo and in vitro binding of carbon tetrachloride with nucleic acids and proteins in rat and mouse liver. Int J Cancer_1973;11:419-25.
4. Sanders V, Tucker A, White K, Kauffmann B, Hallett P, Carchman R, et al. Humoral and cell-mediated immune status in mice exposed to trichloroethylene in the drinking water. Toxicol Appl Pharmacol 1982;62:358-68.
5. Sanders V, White K, Shopp G, Munson A. Humoral and cell-mediated immune status of mice exposed to 1,1,2-trichloroethane. Drug Chem Toxicol 1985;8:357-72.
6. Kauffman B, White K, Sanders V, Douglas K, Sain L, Borzelleca J, et al. Humoral and cell-mediated immune status in mice exposed to chloral hydrate. Environ Health Perspect 1982;44:147-51.
7. Shopp G, Sanders V, White K, Munson A. Humoral and cell-mediated immune status of mice exposed to trans-1,2 dichloroethylene. Drug Chem Toxicol 1985;8:393-407.
8. Khan M, Kaphalia B, Prabhakar B, Kanz M, Ansari G. Trichloroethylene-induced autoimmune response in female MRL +/+ mice. Toxicol Appl Pharmacol 1995;134:155-60.
9. Byers V, Levin A, Ozonoff D, Baldwin R. Association between clinical symptoms and lymphocyte abnormalities in a population with chronic domestic exposure to industrial solvent-contaminated domestic water supply and a high incidence of leukaemia. Cancer Immunol Immunother 1988;27:77-81.
10. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
11. US Department of Commerce, Office of Federal Statistical Power and Standards. The standard occupational classification manual. Washington (DC): US Government Printing Office; 1980.
12. Executive Office of the President, Office of Management and Budget. The standard industrial classification manual. Washington (DC): US Government Printing Office; 1987.
13. Gomez M, Cocco P, Dosemeci M, Stewart P. Occupational exposure to chlorinated aliphatic hydrocarbons: job exposure matrix. Am J Ind Med 1994;26:171-83.
14. Kromhout H, Oostendorp Y, Heederick D, Boleij J. Agreement between qualitative exposure estimates and quantitative exposure measurements. Am J Ind Med 1987;12:551-62.
15. Brasington RD Jr, Thorpe-Swenson AJ. Systemic sclerosis associated with cutaneous exposure to solvent: case report and review of the literature. Arthritis Rheum 1991;34:631-3.
16. Saihan E, Burton J, Heaton K. A new syndrome with pigmentation, scleroderma, gynaecomastia, Raynaud's phenomenon and peripheral neuropathy. Br J Dermatol 1978;99:437-40.
17. Walder B. Solvents and scleroderma. Lancet 1965;ii:436-7.
18. Bovenzi M, Barbone F, Betta A, Tommasini M, Versini W. Scleroderma and occupational exposure. Scand J Work Environ Health 1995;21:289-92.
19. Czirjak L, Bokk A, Csontos G, Lorincz G, Szegedi G. Clinical findings in 61 patients with progressive systemic sclerosis. Acta Derm Venereol 1989;69:533-6.
20. Goldman J. Connective tissue disease in people exposed to organic chemical solvents: systemic sclerosis (scleroderma) in dry cleaning plant and aircraft industry workers. J Clin Rheumatol 1996;2:185-90.
21. Laing T, Gillespie B, Burns C, Garabrant D, Heeringa S, Alcser K, et al. Risk factors for scleroderma among Michigan women [abstract]. Arthritis Rheum 1995;38 Suppl 9:S341.
22. Schaeverbeke T, Halle O, Moride Y, Constans J, Pellegrin JL, Conri C, et al. Systemic sclerosis and prolonged exposure to toxics [abstract]. Arthritis Rheum 1995;38 Suppl 9:S332.
23. Silman A, Jones S. What is the contribution of occupational environmental factors to the occurrence of scleroderma in men? Ann Rheum Dis 1992;51:1322-4.
24. Lundberg I, Alfredsson L, Plato N, Sverdrup B, Klareskog L, Kleinau S. Occupation, occupational exposure to chemicals and rheumatological disease: a register based cohort study. Scand J Rheumatol 1994;23:305-10.
25. Haustein U, Herrmann K. Environmental scleroderma. Clin Dermatol 1994;12:467-73.
26. Bezrodnyhk A, Karelin A. Systemic lupus erythematosus and systemic scleroderma in patients from the aboriginal people and the newcomers of Yakutia under the extreme conditions of the far north. Alaska Med 1994;36:102-6.
27. Matsumoto Y, Kawabe M, Yasue T, Yuguchi M, Yoshida I. Two cases of scleroderma associated with vibration syndrome. Jpn J Dermatol 1989;99:155-61.
28. Pelmear P, Roos J, Maehle W. Occupationally-induced scleroderma. J Occup Med 1992;34:20-5.
29. Messing K, Dumais L, Courville J, Seifert AM, Boucher M. Evaluation of exposure data from men and women with the same job title. J Occup Med 1994;36:913-7.
30. Reveille J, Durban E, MacCleod-St. Clair M, Goldstein R, Moreda R, Altman R, et al. Association of amino acid sequences in the HLA-DQB1 first domain with the antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis). J Clin Invest 1992;90:973-80.
31. Sackett D. Bias in analytic research. J Chronic Dis 1979;32:51-63.
32. Kilburn K, Warshaw R. Prevalence of symptoms of systemic lupus erythematosus and fluorescent antinuclear antibodies associated with chronic exposure to trichloroethylene and other chemicals in well water. Environ Res 1992;57:1-9.
33. Brogren C, Christensen J, Rasmussen K. Occupational exposure to chlorinated organic solvents and its effects on the renal excretion of N-acetyl-beta-D-glucosaminidase. Arch Toxicol Suppl 1986;9:460-4.
34. Dosemeci M, Cocco P, Gomez M, Stewart P, Heineman E. Effects of three features of a job-exposure matrix on risk estimates. Epidemiology 1994;5:124-7.
35. Dosemeci M, Stewart P. Recommendations for reducing the effects of exposure misclassification on relative risk estimates. Occup Hyg 1996;3:169-76.